TENX
NASDAQ
$15.72
Tenax Therapeutics Inc (TENX)
Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing, and marketing products for cardiovascular and pulmonary disease in the United States and Canada. The company is headquartered in Morrisville, North Carolina.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $34.75 (+121.06%)
Market Cap
$372M
FCF 5Y CAGR
+31.16%
Free Cash Flow Yield
-10.24%
Price Chart
Valuation
Market Cap$372M
Forward P/E0.30
P/S414.72
P/B3.54
Profitability
EBITDA-$58M
EPS-$7.61
Financial Health
Free Cash Flow Yield-10.24%
Growth & Risk
FCF 5Y CAGR+31.16%
Sharpe Ratio1.61